Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

European Commission grants marketing approval for Arixtra

March 28, 2002

rNAPc2 safe and effective in phase IIa trial in patients undergoing PCI

March 26, 2002

Novel anticoagulants designed at 3-D

March 25, 2002

Scientists at Takeda present new factor Xa inhibitors

March 22, 2002

Bristol-Myers Squibb presents new compounds for the treatment of thrombosis

March 19, 2002

Lilly describes new series of factor Xa inhibitors

March 19, 2002

Merck & Co. reports new factor Xa and factor VIIa inhibitors

March 18, 2002

Aventis to study prolonged administration of Lovenox in prophylaxis of venous thromboembolism

March 18, 2002

Long-lasting oral antithrombotic efficacy demonstrated for AT-1015 in rat model

March 18, 2002

New guidelines for unstable angina and NSTEMI Rx

March 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...